An animal model for human EBV-associated hemophagocytic syndrome - Herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits
K. Hayashi et al., An animal model for human EBV-associated hemophagocytic syndrome - Herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits, AM J PATH, 158(4), 2001, pp. 1533-1542
Citations number
46
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Epstein-Barr virus-associated hemophagocytic syndrome (EBV-AHS) Is often as
sociated with fatal infectious mononucleosis. However, the animal model for
EBV-AHS has not been developed. We reported the first animal model for EBV
-AHS using rabbits infected with EBV-related herpesvirus of baboon (HVP), E
leven of 13 (85%) rabbits inoculated intravenously with HVP-producing cells
developed fatal lymphoproliferative disorders (LPD) between 22 and 105 day
s after Inoculation. LPD was also accompanied by hemophagocytic syndrome (H
PS) in nine of these 11 rabbits, The peroral spray of cell-free HVP induced
the virus infection with increased anti-EBV-viral capsid antigen-IgG titer
s in three of five rabbits, and two of these three infected rabbits died of
LPD with HPS, Autopsy revealed hepatosplenomegaly and swollen lymph nodes.
Atypical lymphoid T cells expressing EBV-encoded small RNA-I infiltrated d
iffusely in many organs, frequently involving the lymph nodes, spleen, and
liver. Hemophagocytic histiocytosis was observed in the lymph nodes, spleen
, bone marrow, and thymus, HVP-DNA was detected in the tissues and peripher
al blood from the infected rabbits by polymerase chain reaction or Southern
blot analysis. Re-verse transcriptase-polymerase chain reaction revealed b
oth HVP-EBNA1 and HVP-EBNA2 transcripts, suggesting latency type Ri infecti
on. These data indicate that the high rate of rabbit LPD with HPS induction
is caused by HVP, This system is useful for studying the pathogenesis, pre
vention, and treatment of human EBV-AHS.